3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Carcinoma, Intraductal, Noninfiltrating
3
Breast Diseases
3
Neoplasms by Site
2
Neoplasms
2
Neoplasm Metastasis
2
Breast Neoplasms, Male
2
Advanced Breast Cancer
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Ovarian Neoplasms
1
Low Grade Serous Ovarian Cancer
1
Locoregional Recurrence
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
HER2 Negative Breast Cancer
1
Endometrial Neoplasms
1
Breast Neoplasm Female
1
Breast Carcinoma In Situ
1
Anatomic Stage III Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Interventions
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Taxes
1
Radiotherapy, Conformal
1
Paclitaxel
1
Mastectomy, Segmental
1
Mastectomy
1
Carboplatin
1
Brachytherapy
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Anastrozole
×
90 days
×
Clear all
No trials found.